Market Overview

BGI-Shenzhen Extends Tender Offer for Complete Genomics

BGI-Shenzhen ("BGI") announced today that it, through its wholly-owned subsidiary Beta Acquisition Corporation, has extended its all cash tender offer (the "Offer") to purchase all outstanding shares of common stock of Complete Genomics, Inc. (NASDAQ: GNOM) ("Complete") to 12:00 midnight (EST) on Friday, February 1, 2013. The Offer was previously scheduled to expire at 12:00 midnight (EST) on Friday, January 25, 2013. 

Except for the extension of the Offer expiration date, all other terms and conditions of the Offer remain unchanged. The Depositary for the Offer has indicated that, as of the close of business on January 25, 2013, approximately 30,949,757 shares, or approximately 87%, of common stock of Complete have been validly tendered in and not withdrawn from the Offer, including shares of common stock of Complete subject to guaranteed delivery procedures.

BGI's financial advisor is Citi, and its legal counsel is O'Melveny & Myers LLP. Complete's financial adviser is Jefferies & Company, and its legal counsel is Latham & Watkins LLP.

Stockholders with questions about the Offer, or who need assistance with tendering their shares of common stock of Complete, may call the Information Agent, Innisfree M&A Incorporated, toll-free at (888) 750-5834.

FORWARD-LOOKING STATEMENTS

Certain statements

See full press release

Posted-In: News Guidance Management M&A Global

 

Related Articles (GNOM)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters